title: Effect of captopril and melatonin on fibrotic rebuilding of the aorta in 24 hour light-induced hypertension.
abstract: Chronic continuous light exposure leads to melatonin deficiency along with complex neurohumoral activation resulting in hypertension development in rats. The aim of this study was to show, whether continuous light induces fibrotic rebuilding of the aorta and whether the treatment with melatonin or angiotensin converting enzyme inhibitor captopril can prevent these potential alterations. In a six-week experiment, 3-month-old Wistar rats were divided into 4 groups (ten per group): controls, rats exposed to continuous light, exposed to continuous light plus treated with captopril (100 mg/kg/24 h) and exposed to continuous light plus treated with melatonin (10 mg/kg/24 h). Systolic blood pressure (SBP) and collagen type I and III in the media of thoracic aorta were measured. Continuous light induced hypertension and fibrotic rebuilding of the aorta in terms of enhancement of collagen I and III concentration in the aortic media. Both captopril and melatonin prevented SBP rise and reduced collagen III concentration in the aorta. However, only melatonin reduced collagen I and the sum of collagen I and III in the aortic tissue. We conclude that in continuous light-induced hypertension, administration of melatonin, along with SBP reduction, decreases collagen I and III concentration in the aorta. It is suggested that antifibrotic effect of melatonin may reduce the stiffness of the aorta and small arteries and beneficially influence the nature of the pulse wave and peripheral vascular resistance.
authors: Department of Pathophysiology, School of Medicine, Comenius University, Bratislava, Slovak Republic. fedor.simko@fmed.uniba.sk.
authors: K
authors: K
authors: Repová-Bednárová
authors: S
authors: S
authors: Aziriová
authors: J
authors: J
authors: Hrenák
authors: K
authors: K
authors: Krajčírovičová
authors: M
authors: M
authors: Adamcová
authors: L
authors: L
authors: Paulis
authors: F
authors: F
authors: Simko
mesh_terms: D000818:Animals; D000933:Antifibrinolytic Agents / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001011:Aorta / Q000187:drug effects / Q000503:physiopathology*; D002216:Captopril / Q000008:administration & dosage*; D024022:Fibrillar Collagens / Q000378:metabolism; D006973:Hypertension / Q000209:etiology* / Q000503:physiopathology* / Q000517:prevention & control; D008027:Light / Q000009:adverse effects; D008297:Male; D008550:Melatonin / Q000008:administration & dosage*; D010775:Photic Stimulation / Q000009:adverse effects*; D051381:Rats; D017208:Rats, Wistar; D059289:Vascular Stiffness / Q000187:drug effects*
chemical_list: D000933:Antifibrinolytic Agents; D000959:Antihypertensive Agents; D024022:Fibrillar Collagens; D002216:Captopril; D008550:Melatonin